Kalytera Therapeutics Appoints Dr. Stuart Silverman as Senior Vice President of Medical Affairs
MANHATTAN BEACH, CA -- (Marketwired) -- 06/27/16 -- Kalytera Therapeutics, Inc., a pharmaceutical company developing a portfolio of proprietary cannabinoid and endocannabinoid-like medicines, today announced the appointment of Dr. Stuart Silverman, M.D., …